The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Results of Surgical and Nonsurgical Treatment for Small–Sized Hepatocellular Carcinomas: A Retrospective and Nationwide Survey in Japan
Open accessAbstract
Hepatic resection (HX), percutaneous ethanol injection (PEI), and transcatheter arterial embolization (TCAE) have all been used in the treatment of patients with small–sized hepatocellular carcinomas (HCCs). However, the indications for these therapeutic modalities remain unclear. Therefore, the first step to minimize the debate on these indications is to review the standard results from each treatment based on an extensive survey. The participants in this study were patients with HCCs less than 5 cm in diameter who were enrolled in The Liver Cancer Study Group of Japan. The survival rates in the HX (n = 8,010), PEI (n = 4,037), and TCAE (n = 841) groups were calculated in relation to the number of tumors and the clinical stage. In the clinical stage I cases with a solitary tumor less than 2 cm in diameter and in all clinical stages with a solitary tumor greater than 2 cm and in the clinical stage II cases with 2 tumors greater than 2 cm, the HX group showed higher survival rates than the nonsurgical groups. The HX group had a higher male/female ratio and a younger mean age than the PEI or TCAE group. The ratio of HBs antigen–positive cases/hepatitis C virus antibody–positive cases in the PEI group was lower than that in the corresponding HX group. In contrast, the PIVKA–II values in the HX group tended to be higher than in the PEI group. In conclusion, these findings will provide useful information for selection of a therapeutic modality for small–sized HCCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Livraghi, T., Giorgio, A., Marin, G., Salmi, A., de Sio, I., Bolondi, L., Pompili, M., Brunello, F., Lazzaroni, S., & Torzilli, G. (1995) · Radiology · doi:10.1148/radiology.197.1.7568806 · Cited by 939
(1995) · New England Journal of Medicine · doi:10.1056/nejm199505113321903 · Cited by 809
An Analysis of 412 Cases of Hepatocellular Carcinoma at a Western Center
Fong, Y., Sun, R. L., Jarnagin, W., & Blumgart, L. H. (1999) · Annals of Surgery · doi:10.1097/00000658-199906000-00005 · Cited by 796
Ikeda, K. (1993) · Hepatology · doi:10.1016/0270-9139(93)90505-h · Cited by 620
Ikeda, K., Saitoh, S., Koida, I., Arase, Y., Tsubota, A., Chayama, K., Kumada, H., & Kawanishi, M. (1993) · Hepatology · doi:10.1002/hep.1840180109 · Cited by 538
(1992) · Springer eBooks · doi:10.1007/978-4-431-68177-9 · Cited by 434
Hepatocellular carcinoma in the United States: Prognostic features, treatment outcome, and survival
Stuart, K. E., Anand, A. J., & Jenkins, R. L. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960601)77:11<2217::aid-cncr6>3.0.co;2-m · Cited by 354
Primary liver cancers in Japan
Okuda, K., & Liver Cancer Study Group of Japan (1980) · Cancer · doi:10.1002/1097-0142(19800515)45:10<2663::aid-cncr2820451030>3.0.co;2-g · Cited by 336
Tobe, T., Uchino, J., Endo, Y., Oto, M., Okamoto, E., Kojiro, M., Shikata, T., Tanikawa, K., Tsuzuki, T., Mizumoto, R., et al. (1994) · Cancer · doi:10.1002/1097-0142(19941115)74:10<2772::aid-cncr2820741006>3.0.co;2-v · Cited by 335
Self-citationResection of hepatocellular carcinomas
Franco, D., Capussotti, L., Smadja, C., Bouzari, H., Meakins, J., Kemeny, F., Grange, D., & Dellepiane, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90296-d · Cited by 315
Primary treatment of hepatocellular carcinoma by arterial chemoembolization
Bismuth, H., Morino, M., Sherlock, D., Castaing, D., Miglietta, C., Cauquil, P., & Roche, A. (1992) · The American Journal of Surgery · doi:10.1016/0002-9610(92)90039-t · Cited by 260
Hepatocellular Carcinoma and Cirrhosis: Results of Surgical Treatment in a European Series
Fuster, J., García-Valdecasas, J. C., Grande, L., Tabet, J., Bruix, J., Anglada, T., Taurá, P., Lacy, A. M., González, X., Vilana, R., et al. (1996) · Annals of Surgery · doi:10.1097/00000658-199603000-00011 · Cited by 227
Classification of primary liver cancer
日本肝癌研究会 (1997) · Medical Entomology and Zoology · Cited by 203
Primary liver cancer in Japan. Sixth report
THE LIVER CANCER STUDY GROUP of JAPAN (1987) · Cancer · doi:10.1002/1097-0142(19870915)60:6<1400::aid-cncr2820600639>3.0.co;2-w · Cited by 172
Upper abdominal computerized tomography scanning in staging non-small cell lung carcinoma
Chapman, G. S., Kumar, D., Redmond, J., Munderloh, S. H., & Gandara, D. R. (1984) · Cancer · doi:10.1002/1097-0142(19841015)54:8<1747::aid-cncr2820540846>3.0.co;2-l · Cited by 48
Cited by
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Chen, M.-S., Li, J.-Q., Zheng, Y., Guo, R.-P., Liang, H.-H., Zhang, Y.-Q., Lin, X.-J., & Lau, W. Y. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201480.65519.b8 · Cited by 1,432
Metadata
- Authors
- Arii, S., Yamaoka, Y., Futagawa, S., Inoue, K., Kobayashi, K., Kojiro, M., Makuuchi, M., Nakamura, Y., Okita, K., & Yamada, R.
- Venue
- Hepatology
- Published
- 2000-12
- Volume
- 32
- Issue
- 6
- Pages
- 1224-1229
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1966636348
- Cited by
- 725
- References
- 15
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.